Home India board rules against Bayer in cancer drug patent case
 

Keywords :   


India board rules against Bayer in cancer drug patent case

2013-03-04 18:07:46| Biotech - Topix.net

An Indian patent appeals board upheld on Monday a decision to allow a domestic company to sell a generic version of Bayer AG's cancer drug Nexavar, in a blow for global drugmakers' efforts to hold on to monopolies on high-price medicines.

Tags: case board rules india

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
06.10Weekly Recap: Ontex Enters Agreement to Sell Brazilian Business, Winner Acquires Stake in GRI ...
06.10Tropical Storm Milton Graphics
06.10Tropical Storm Milton Public Advisory Number 4A
06.10Summary for Tropical Storm Milton (AT4/AL142024)
06.10Atlantic Tropical Weather Outlook
06.10Eastern North Pacific Tropical Weather Outlook
06.10Ex-cabinet secretary says 200,000 job is underpaid
06.10Hurricane Leslie Graphics
More »